Research into Fallopian tube cancer spans multiple therapeutic approaches and trial phases.

65 total trials for this combination

Showing top 10 of 65 trials

Trials

NCT ID	Title	Status	Phase
NCT03038100	A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	COMPLETED	PHASE3
NCT01204749	TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer	COMPLETED	PHASE3
NCT00268918	Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients	COMPLETED	PHASE1
NCT03849469	A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors	COMPLETED	PHASE1
NCT01493505	TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer	TERMINATED	PHASE3
NCT05445778	Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer	RECRUITING	PHASE3
NCT02657889	Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer	COMPLETED	PHASE1/PHASE2
NCT04209855	A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression	COMPLETED	PHASE3
NCT05377996	A Study of XMT-1660 in Participants With Solid Tumors	RECRUITING	—
NCT05377996	A Study of XMT-1660 in Participants With Solid Tumors	RECRUITING	—

Related Pages

All Fallopian tube cancer trials All trials in Boston, United States